Cargando…

Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor

HIGHLIGHTS: This prospective study is one of the largest clinical trials in essential tremor to date. Study findings suggest that individualized non-invasive neuromodulation therapy used repeatedly at home over three months results in safe and effective hand tremor reduction and improves quality of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaacson, Stuart H., Peckham, Elizabeth, Tse, Winona, Waln, Olga, Way, Christopher, Petrossian, Melita T., Dahodwala, Nabila, Soileau, Michael J., Lew, Mark, Dietiker, Cameron, Luthra, Nijee, Agarwal, Pinky, Dhall, Rohit, Morgan, John, Calakos, Nicole, Zesiewicz, Theresa A., Shamim, Ejaz A., Kumar, Rajeev, LeWitt, Peter, Shill, Holly A., Simmons, Adam, Pagan, Fernando L., Khemani, Pravin, Tate, Jessica, Maddux, Brian, Luo, Lan, Ondo, William, Hallett, Mark, Rajagopal, Apoorva, Chidester, Paula, Rosenbluth, Kathryn H., Delp, Scott L., Pahwa, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427656/ https://www.ncbi.nlm.nih.gov/pubmed/32864188 http://dx.doi.org/10.5334/tohm.59

Ejemplares similares

An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor
por: Pahwa, Rajesh, et al.
Publicado: (2019)

Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor
por: Brillman, Salima, et al.
Publicado: (2022)

Noninvasive neuromodulation in essential tremor demonstrates relief in a sham‐controlled pilot trial
por: Lin, Peter T., et al.
Publicado: (2018)

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson’s Disease
por: Brillman, Salima, et al.
Publicado: (2023)

Blepharospasm plus Cervical Dystonia with Predominant Anterocollis: A Distinctive Subphenotype of Segmental Craniocervical Dystonia
por: Waln, Olga, et al.
Publicado: (2011)

A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor
por: Papapetropoulos, Spyros, et al.
Publicado: (2021)

IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial
por: Hauser, Robert A., et al.
Publicado: (2023)

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016)

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study
por: Kassubek, Jan, et al.
Publicado: (2023)

An Update on Tardive Dyskinesia: From Phenomenology to Treatment
por: Waln, Olga, et al.
Publicado: (2013)

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Presynaptic long-term plasticity
por: Yang, Ying, et al.
Publicado: (2013)

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
por: LeWitt, Peter A., et al.
Publicado: (2018)

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy
por: Espay, Alberto J., et al.
Publicado: (2017)

Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation
por: LeWitt, Peter, et al.
Publicado: (2023)

Musculoskeletal modelling of an ostrich (Struthio camelus) pelvic limb: influence of limb orientation on muscular capacity during locomotion
por: Hutchinson, John R., et al.
Publicado: (2015)

Confocal Analysis of Cholinergic and Dopaminergic Inputs onto Pyramidal Cells in the Prefrontal Cortex of Rodents
por: Zhang, Zi-Wei, et al.
Publicado: (2010)

Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009)

Characterization of Vitamin B12 Supplementation and Correlation with Clinical Outcomes in a Large Longitudinal Study of Early Parkinson’s Disease
por: Dietiker, Cameron, et al.
Publicado: (2019)

Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring
por: Isaacson, S.H., et al.
Publicado: (2022)

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Implementation of K-matrix formalism in the D0 -> K_s pi+ pi- amplitude model
por: Petrossian-Byrne, Rudin
Publicado: (2014)

Implementation of K-matrix formalism in the D0 -> K_s pi+pi- amplitude model
por: PETROSSIAN-BYRNE, Rudin
Publicado: (2014)

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
por: Patel, Atul T., et al.
Publicado: (2021)

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
por: Patel, Atul T., et al.
Publicado: (2021)

Managing the risk of suicide in a psychiatry clinic: an ethnographic study on the work atmosphere of nurses during the pandemic period
por: Öztürk, S., et al.
Publicado: (2023)

The Interrelated Multifactorial Actions of Cortisol and Klotho: Potential Implications in the Pathogenesis of Parkinson’s Disease
por: Luthra, Nijee S., et al.
Publicado: (2022)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Timing of the Sense of Volition in Patients With Schizophrenia
por: Pirio Richardson, Sarah, et al.
Publicado: (2020)

Transcutaneous Afferent Patterned Stimulation Therapy Reduces Hand Tremor for One Hour in Essential Tremor Patients
por: Yu, Jai Y., et al.
Publicado: (2020)

Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial
por: Isaacson, Stuart H., et al.
Publicado: (2020)

Commentary on “Sacroiliac joint fusion in patients with Ehlers Danlos syndrome: A case series”
por: Dahodwala, Taikhoom, et al.
Publicado: (2023)

Commentary on “Clinical relevance of occult infections in spinal pseudarthrosis revision”
por: Dahodwala, Taikhoom, et al.
Publicado: (2023)

Description of a New Labyrinthine Dehiscence: Horizontal Semicircular Canal Dehiscence at the Tympanic Segment of the Facial Nerve
por: Gianoli, Gerard, et al.
Publicado: (2022)

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT(1A) Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression
por: Rapaport, Mark H., et al.
Publicado: (2002)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?
por: Hauser, Robert A., et al.
Publicado: (2023)

Internal Medicine Trainee Understanding and Reaction to Out of Pocket Costs
por: Chidester, Jeffrey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0iib6otr4goi48o8d7hsfut6me